Most clinical trials pay between $1,000 and $4,000 total, with a median of about $3,070 for Phase 1 studies involving healthy volunteers. The range is enormous, though. A simple vaccine trial with no overnight stay might pay $150, while a cancer study requiring 34 consecutive days in a research clinic paid $13,000. What you earn depends on the time commitment, the procedures involved, and how much the study disrupts your daily life.
Typical Pay Ranges
A study of nearly 1,000 Phase 1 clinical trials found that 65% offered less than $4,000 in total compensation. About 23% paid under $2,000, while only 2% crossed the $10,000 mark. The median daily rate across all studies was $196 per day enrolled, but that rate climbed with the total study price tag. Trials paying under $2,000 total had a median daily rate of $135, while those paying $10,000 or more averaged closer to $293 per day.
When broken down hourly, compensation for Phase 1 studies (where healthy volunteers test a drug’s safety) typically works out to $10 to $20 per hour. That’s not high pay by most standards, especially given the constraints. Phase 1 participants are often confined to a research clinic for days or weeks, with controlled meals, restricted movement, and frequent monitoring.
Later-phase trials (Phase 2 and Phase 3) tend to involve patients who already have the condition being studied. These trials often pay less in direct stipends, sometimes nothing at all, because participants may benefit from access to experimental treatments. When they do pay, it’s usually per-visit compensation rather than a lump sum for confinement.
What Drives the Pay Up or Down
Three factors determine what a study pays: how long it takes, how invasive the procedures are, and how much it disrupts your normal routine.
Time is the biggest driver. A single outpatient visit with a blood draw pays far less than a multi-week inpatient stay. Studies that require overnight confinement in a clinic compensate for the fact that you can’t work, go home, or maintain your regular schedule. Some facilities offer non-financial perks during long stays, like entertainment, haircuts, or massages, to make the experience more bearable.
Invasive procedures also increase pay. The National Institutes of Health uses an “inconvenience unit” system (each unit worth $10) to benchmark what procedures are worth to participants. A standard blood draw is valued at about $20 in added compensation. A lumbar puncture (spinal tap) adds around $50. Biopsies, PET scans, and procedures that carry more discomfort or risk sit at the higher end. These amounts get layered on top of the base compensation for your time.
How You Get Paid
Payment methods vary by institution. Prepaid Visa debit cards are increasingly common, offered either as one-time-load cards or reloadable cards that function like a basic bank account. Some research sites use digital platforms that let you choose between Visa gift cards, retail gift cards (Amazon, Target, Walmart), or transfers through Venmo or PayPal. Cash and paper checks still exist but are becoming less standard. You’ll know the payment method before you enroll.
Federal guidelines require that payment be prorated as the study progresses rather than withheld until the end. If you enroll in a 10-visit study and withdraw after 6 visits, you’re entitled to compensation for those 6 visits. Studies are allowed to offer a small completion bonus as an incentive to finish, but the bonus can’t be so large that it pressures you to stay in a study you want to leave. The specific payment schedule, including what happens if you withdraw early, should be spelled out clearly before you consent.
Taxes on Clinical Trial Earnings
Clinical trial payments count as taxable income. If a single institution pays you more than $599 in a calendar year, it’s required to report those payments to the IRS on a Form 1099. You’re responsible for reporting the income on your tax return regardless of whether you receive a 1099. Reimbursements for actual expenses like parking, gas, or travel don’t count toward that threshold, but the stipend portion does.
If you participate in multiple studies across different institutions, each one tracks its payments to you independently. You could earn $500 from three different sites and never receive a 1099 from any of them, but you’d still technically owe taxes on the full $1,500.
Expense Reimbursements on Top of Pay
Most studies reimburse travel costs separately from the participation stipend. At the NIH, the government mileage rate (currently around 58.5 cents per mile) is the benchmark, though individual studies can set their own rate. For participants traveling more than 50 miles, studies may cover meals (the government rate is $64 per day) and lodging (up to $201 per night). Shorter-distance travelers typically get mileage reimbursement plus coverage for taxis, buses, or trains. These reimbursements are not considered income and won’t appear on your 1099.
Why Pay Varies So Much
Clinical trial compensation is reviewed by an institutional review board (IRB) before any participants are recruited. The IRB’s job is to make sure pay is fair without being so high that it clouds your judgment about the risks involved. The FDA calls this “undue inducement,” meaning payment that’s large enough to push someone into accepting risks they wouldn’t otherwise take. This is why you won’t see clinical trials advertising $50,000 payouts. The system is designed to compensate your time and inconvenience, not to make participation irresistible.
In practice, this means pay tends to be modest relative to the time involved. A two-week inpatient study paying $4,000 sounds significant until you calculate that it works out to roughly $12 an hour for a 24-hour-a-day commitment. People who participate in Phase 1 trials regularly, sometimes called “professional guinea pigs,” often string together multiple studies per year to make it financially viable. For later-phase trials involving patients with specific conditions, the real value is often access to cutting-edge treatments rather than the stipend itself.